Another key role in the economy roaring back to life is Pfizer's game-changing news about its experimental COVID-19 pill. The company said its pill cuts the risk of death or hospitalization by 89%.
Shares of the company surged Friday morning — up nearly 10% before coming back down a bit.
If what Pfizer is saying is true and this pill is approved by the FDA, we’re looking at what could be the end of the COVID-19 era.
But to me, what’s even crazier about Pfizer’s COVID-19 pill news is that I sent out a free trade alert for traders to get into the stock two days before the news hit.
And that’s not the only stock I’m watching this week.
Anyone placing trades during the week may actually be stacking the cards against themselves…
Look, every week, thousands of headlines like earnings or bad news out of the Federal Reserve or China wreck what may seem to be perfectly good trade setups.
So instead of traders risking their hard-earned cash during the meat of the week, there’s a simple Friday afternoon strategy that is able to skip all of the madness…
It taps into some of the most reliable forces in the market, already giving New Money Crew Head Trader Lance Ippolito direct access to trade gains like 90% on ZNGA… 96% on INTC… and even 610% on CRSR!
2 Stocks With Supersonic Gains From Massive Military Spending
November 03, 2021
It’s widely known that the U.S. leads the pack when it comes to developing the most advanced military tech. But we’re finally experiencing something we haven’t seen in decades...
The Reopening Trade Is BACK! 3 Stocks to Watch
November 05, 2021
The current reality on Wall Street is we’re on the crux of the reopening trade completely running the markets...
Disclaimer: The material in this document is for informational purposes based on our proprietary research. It is not an offering, specific recommendation, or a solicitation of an offer to buy or sell any securities mentioned or discussed herein.
Any performance results discussed herein represent past performance, are not a guarantee of future performance, and are not indicative of any specific investment.
Due to the timing of information presented, any investment performance reflected within this document may be adjusted after the publication and distribution of this material. There can be no assurance that the future performance of any specific investment, investment strategy, or product made reference to directly or indirectly in this communication will be profitable, be equal to any corresponding indicated historical performance levels or be suitable for your portfolio. Any investment results set forth in this document are not net of expenses and execution costs, nor do they account for other relevant trading or investment fees. Please visit wealthpress.com/terms for our full Terms and Conditions.
0 Response to "2 Stocks I’m Looking at Going into Monday Morning"
Post a Comment